HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Quote:
Login Free Membership
Search:

Press Releases  

Zacks Releases Four Powerful ''Buy'' Stocks: Western Refining, Ross Stores, Watson Pharmaceuticals and Steven Madden

Share
September 30, 2011 | Comment(s): 0
Recommended this article (6)
WNR | ROST | WPI | SHOO

For Immediate Release

Chicago, IL – September 30, 2011 – Four free stock picks are being made available today on Zacks.com. The industry’s leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.

The four highlighted picks are: Western Refining Inc. (WNR - Analyst Report), Ross Stores, Inc. (ROST - Snapshot Report), Watson Pharmaceuticals, Inc. (WPI - Analyst Report) and Steven Madden Limited (SHOO - Snapshot Report).

Today, Zacks is promoting its ''Buy'' stock recommendations. Four daily picks are offered free. http://at.zacks.com/?id=88

From 1988 through the present – a period that included serious corrections and recessions – the Zacks #1 Rank Stocks have nearly tripled the market with a fully documented average gain of +28% per year.

Here is a summary of today's selected stocks that are now highly rated by Zacks:          

Aggressive Growth – Western Refining Inc. (WNR - Analyst Report)
Western Refining Inc. has been a wild ride lately, but estimates are rising rapidly which has created dirt-cheap valuations.

Zacks Guide to Aggressive Growth Investing (free!) - http://at.zacks.com/?id=4309

Growth & Income – Ross Stores, Inc. (ROST - Snapshot Report)
Earnings estimates continue to climb for Ross Stores, Inc. as the company delivers month after month of strong same-store sales growth. It is a Zacks #2 Rank (Buy) stock.

Zacks Guide to Growth & Income Investing (free!) - http://at.zacks.com/?id=4310

Momentum – Watson Pharmaceuticals, Inc. (WPI - Analyst Report)
Watson Pharmaceuticals, Inc. recently hit a 3-year high even as the global stock markets shook with volatility. This Zacks #2 Rank (buy) also is expected to see double digit earnings growth in 2011. Who says the drug company stocks are boring?

Zacks Guide to Momentum Investing (free!):  http://at.zacks.com/?id=4311

Value –
Steven Madden Limited (SHOO - Snapshot Report)
Shoes are still hot. Steven Madden Limited reported record second quarter results in August as sales jumped 32%. This Zacks #2 Rank (buy) stock has also moved into value territory, with a forward P/E of 14.7.

Zacks Guide to Value Investing (free!) -  http://at.zacks.com/?id=4312

How to Regularly Access Top Zacks Rank Picks for Free - http://at.zacks.com/?id=7154

Underlying the four free stock picks is a simple truth that first appeared in a Financial Analysts Journal article published in 1979. Leonard Zacks, a Ph.D. from M.I.T. found that "earnings estimate revisions are the most powerful force impacting stock prices."  Zacks #1 Rank is awarded to a stock when analysts sharply upgrade their estimates of what the company will earn.

Today, Zacks is promoting its stock recommendations by offering four daily picks free to those who register here: http://at.zacks.com/?id=7155

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms.  It monitors more than 200,000 earnings estimates, looking for changes.

Then, when changes are discovered, they’re applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock-picking system continues to outperform the market by a nearly 3-to-1 margin.  

More Free Stock Picks

Each weekday, new Zacks #1 Rank or Zacks #2 Rank stock picks are released on the free email newsletter, Profit from the Pros. Investors are invited to register for their free subscription here: http://at.zacks.com/?id=91

 Follow us on Twitter:  http://twitter.com/zacksresearch

 Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Read the full analyst report on WNR

Read the full analyst report on ROST

Read the full analyst report on WPI

Read the full analyst report on SHOO

 

Please login to Zacks.com or register to post a comment.



Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
Sell These Stocks Today
Make sure no Zacks #5 Rank "Strong Sell" stocks are lurking in your portfolio. They tend to perform only 1/6th as well as the market!
Get your free Welcome Gifts today*:
 1.  Zacks "Strong Sell" list.
 2.  Our e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 26, 2012 14:24 pm ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center